The Discounted Cash Flow (DCF) valuation of Bionano Genomics Inc (BNGO) is (1,138.93) USD. With the latest stock price at 4.05 USD, the upside of Bionano Genomics Inc based on DCF is -28221.8%.
Based on the latest price of 4.05 USD and our DCF valuation, Bionano Genomics Inc (BNGO) is a sell. selling Bionano stocks now will result in a potential gain of 28221.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 26.7% | 16.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (8,448.85) - (573.81) | (1,138.93) |
| Upside | -208713.5% - -14268.2% | -28221.8% |